SIRO Clintech reloaded
Corporate history is replete with examples of the ‘third generation curse’, but the Daftary family seem to be bucking that trend.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Features
From scale to science: Ahmedabad’s pharma ecosystem at crossroads
The Formulation Development and Drug Delivery (FDD) Conclave has become a meeting ground for India's formulation R&D…
India-US pharma ties look beyond generics
Sergio Gor, US Ambassador to India and Devendra Fadnavis, Maharashatra CM pitch deeper R&D, investment and co-development, at…
The next move on India’s trade chessboard
As tariffs dominate global trade discussions, India's expanding FTA network promises wider market access for Indian pharma. But…
FDD Leadership Awards spotlight FR&D excellence
Continuing its tradition of recognising excellence, the FDD Leadership Awards 2026, held alongside the FDD Conclave 2026,…
FDD Conclave 2026: Charting the future of formulation science and drug delivery
The pharma industry is entering an era where scientific innovation must move faster, scale smarter and remain affordable. Against…
The innovation litmus test
Every industry eventually reaches a point where yesterday's biggest strength is no longer tomorrow's biggest differentiator. For…
Odisha’s pharma pitch
The recently held Odisha Pharma Summit 2025, the state’s first dedicated summit focused on pharmaceuticals, medical devices, and…
Manufacturing the right talent
As pharma manufacturing evolves to meet dynamic market demands, regulatory shifts and technological advancements,Kavita Jani…
Revolutionising outcomes: Agile CROs lead the way
Vivek Chopra, Partner, Vector Consulting Group, and Alka, Senior Consultant, Vector Consulting Group detail the evolving role of…
A digital makeover: Rx for pharma’s success
As pharma industry undergoes a digital renaissance, industry leaders share insights on the pivotal role of technology in…
Cracking the code – Generic vs. Brand Medicines
Dr Suresh Saravdekar, Former Assistant Director, Ministry of Medical Education & Research and Honorary Consultant, Institute…
Is India capable of ensuring equitable access to biopharmaceuticals?
By introducing cost-effective drugs for critical illness by leveraging path-breaking manufacturing technologies, India could…
Three lessons from Pharmanovia’s ESG Report
Neeshe Williams, General Counsel and Head of ESG at Pharmanovia opines that the pharma industry has renewed its focus on…
Transgender inclusion in healthcare: Breaking barriers and creating equitable clinical trials
Jahanara Nayar Rahuldev, Diversity Equity Inclusion India Lead, Parexel accentuates that diversity, equity and inclusion in…
JB Pharma: Betting big on India
Our biggest bet is India and the CDMO space, says Nikhil Chopra, CEO, JB Pharma, taking stock of the company's ongoing transition…
Tech and policy evolution of India’s pharma supply chain
Dinesh Tarachandani, Head – Global Logistics, DP World Subcontinent points out that as the pharma industry accelerates its digital…
How will green chemistry transform the future of pharma manufacturing
Implementing green chemistry in pharma manufacturing can reduce waste and pollution, improve efficiency, and promote…
Futuristic approach to Regulatory Intelligence
Umesh Kurra, Manager – Global Regulatory Services, Freyr Solutions elaborates about the right approach to regulatory intelligence…
Reverse brain drain: Accelerated by COVID-19
Ankit Goyal, Healthcare and Lifesciences Leader India, Heidrick & Struggles finds that leadership hiring is attracting…